Market Overview

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

22.98 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2018
Pre-Market
EPS:
REV:
1.04
2.219B



Q2 2018
Pre-Market
EPS:
REV:
1.05
2.233B



Q1 2018
Pre-Market
EPS:
REV:
0.78
2.109B



Q4 2017
Pre-Market
EPS:
REV:
1.26
2.403B



Q3 2017
Pre-Market
EPS:
REV:
1.55
2.48B

297.08M
1.04
2.219B

6.469369%
Q2 2017
Pre-Market
EPS:
REV:
1.4
2.42B

1.05
2.233B

Q1 2017
Pre-Market
EPS:
REV:
1.55
2.76B

0.78
2.109B

Q4 2016
Pre-Market
EPS:
REV:

1.22
2.34B
1.26
2.403B
0.032787%
0.026923%
Q3 2016
Pre-Market
EPS:
REV:
2.5
2.789B
1.76
2.5B
1.55
2.48B
-11.931818%
-0.8%
Q2 2016
Pre-Market
EPS:
REV:
2.74
2.787B
1.48
2.46B
1.4
2.42B

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!